Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...

Abivax (NASDAQ:ABVX) shares fell sharply on Tuesday after investors focused on reports of rare malignancy cases in a ...

Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) ...

ABIVAX Société Anonyme stock plunged after Phase 3 UC data: efficacy strong but safety flags. Click for this updated look at ...

The company dismissed the cancers observed in the trial as rare, occurring primarily in older patients, and largely unrelated ...

We hope you've had a chance to review the press release we issued after market close in the U.S. today, announcing the positive top-line results of the Phase III ABTECT Maintenance trial. Joining me ...

Exhibiting a favorable safety profile and durable efficacy, Abivax plans to submit an NDA to the FDA in the fourth quarter of 2026.

Cigarette smokers have a significantly lower likelihood of being diagnosed with Sjögren's disease, with histologic data showing less tissue damage and lower disease activity in smokers who have it.

Abivax stock plummeted Tuesday after several patients developed cancer following a study of its ulcerative colitis treatment.

Shelly Nastor has made a point of spreading awareness and fundraising for Crohn’s and Colitis causes since her daughter was diagnosed with colitis at the age of 12, This Sunday, ...

Abivax (ABVX) plunged in premarket trading on Tuesday despite announcing positive Phase 3 maintenance trial results for its ...

According to IQVIA moving annual total data for the twelve months ending April 2026, the US market for Tofacitinib Tablets ...